Acetaminophen mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Acetaminophen Mechanism of Action: Prostaglandin Synthesis Inhibition and Central Effects
Inhibition of Prostaglandin H2 Synthase (PGHS) and Cyclooxygenase (COX) Enzymes
Acetaminophen (paracetamol) primarily works by inhibiting the synthesis of prostaglandins, which are molecules involved in pain and fever. It does this by acting on the enzyme prostaglandin H2 synthase (PGHS), which has two main forms: PGHS-1 and PGHS-2, also known as COX-1 and COX-2. Unlike traditional NSAIDs, acetaminophen does not block the COX site directly. Instead, it acts as a reducing cosubstrate at the peroxidase (POX) site of PGHS, reducing the enzyme’s activity and thus lowering prostaglandin production, especially in the central nervous system (CNS) 110. This central inhibition explains its strong antipyretic (fever-reducing) and analgesic (pain-relieving) effects, but it has weak anti-inflammatory and antiplatelet actions because it is less effective in tissues with high peroxide levels, such as inflamed tissues and platelets 1410.
Role of Peroxide Tone and Cell Selectivity
The effectiveness of acetaminophen in inhibiting prostaglandin synthesis depends on the "peroxide tone"—the level of hydroperoxides in the cell. In cells with low peroxide levels, such as neurons and endothelial cells, acetaminophen is more effective. In contrast, in cells with high peroxide levels, like activated platelets and inflammatory cells, its inhibitory effect is much weaker. This explains why acetaminophen is not a strong anti-inflammatory or antiplatelet agent 1410.
Metabolism to AM404 and Central Analgesic Mechanisms
A significant part of acetaminophen’s analgesic action is due to its metabolism. In the body, acetaminophen is converted to p-aminophenol, which crosses into the brain and is further metabolized by fatty acid amide hydrolase (FAAH) to form AM404. AM404 acts on several central targets: it activates cannabinoid CB1 receptors and transient receptor potential vanilloid 1 (TRPV1) receptors, both of which are involved in pain modulation in the brain and spinal cord 2569+1 MORE. This metabolite can also inhibit prostaglandin synthesis in the CNS, further contributing to pain relief 2569.
Involvement of Serotonergic and Other Neurotransmitter Systems
Acetaminophen also reinforces descending inhibitory pain pathways in the CNS, particularly those involving serotonin. It enhances the activity of serotonergic neurons, which help suppress pain signals. This effect is blocked by serotonin antagonists, confirming the involvement of central serotonergic mechanisms in acetaminophen’s analgesic action 579.
Lack of COX-3 Relevance in Humans
There has been speculation about a third COX isoform, COX-3, as a target for acetaminophen. However, current evidence shows that a functional COX-3 enzyme does not exist in humans, and acetaminophen’s effects are best explained by its actions on COX-1 and COX-2, modulated by peroxide tone and cell type 1345.
Conclusion
Acetaminophen relieves pain and reduces fever mainly by inhibiting prostaglandin synthesis in the CNS through a unique mechanism at the peroxidase site of PGHS, which is highly dependent on cellular peroxide levels. Its analgesic effects are also mediated by its metabolite AM404, which acts on cannabinoid and TRPV1 receptors, and by enhancing central serotonergic pain-inhibiting pathways. These combined actions explain acetaminophen’s effectiveness as an analgesic and antipyretic, and its lack of strong anti-inflammatory or antiplatelet effects 1245+4 MORE.
Sources and full results
Most relevant research papers on this topic
Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action
Acetaminophen's analgesic effects are primarily due to its metabolite AM404, which acts on TRPV1 and cannabinoid 1 receptors in the brain and spinal cord, providing pain relief in both areas.
Mechanism of action of acetaminophen: is there a cyclooxygenase 3?
Acetaminophen may inhibit a third cyclooxygenase, COX-3, which may have different molecular characteristics than COX-2.
DOI